C

CNS Healthcare | Clinical Neuroscience Solutions - Memphis

Research site
(Unclaimed)
Location
6401 Poplar Avenue, Suite 420, Memphis, Tennessee, United States of America
Site insights

Top conditions

Migraine Disorders (3 trials)

Depressive Disorder (2 trials)

Hypogonadism (2 trials)

Major Depressive Disorder (2 trials)

Depression (2 trials)

Top treatments

Cariprazine
Testosterone
Eptinezumab
Risankizumab
BOTOX
TNX-601
AD109
Sildenafil
Atogepant

Parent organization

This site is a part of CNS Healthcare

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

3 of 11
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease

The study consists of 4 sub-studies, as follows:Sub-study 1 (Randomized, double-blind, placebo controlled study) to evaluate the efficacy and safety...

Active, not recruiting
Crohn's Disease
Drug: Risankizumab SC
Drug: Risankizumab On-Body Injector (OBI)

This is a Phase 3 Randomized Double-Blind Placebo-Controlled 1-year Parallel-Arm Study to Compare a Fixed Dose Combination of AD109 to Placebo in Obs...

Enrolling
OSA
Drug: Placebo
Drug: AD109

Migraine is a neurological disease characterized by moderate or severe headache, associated with nausea, vomiting, and/or sensitivity to light and so...

Active, not recruiting
Episodic Migraine
Drug: BOTOX
Drug: Placebo

Trial sponsors

AbbVie logo

AbbVie (6 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems